Home Microsoft CVE-2026-32219
Back to Microsoft

CVE-2026-32219

Windows - Brokering File System

Microsoft CVSS 7 Updated April 16, 2026

Executive Risk Summary

"A double free vulnerability in the Microsoft Brokering File System allows an authorized attacker to elevate privileges locally, potentially leading to unauthorized access to sensitive data and system resources. This vulnerability can be exploited by an attacker with valid credentials to gain elevated privileges on the affected system."

Anticipated Attack Path

  1. 1. Initial Exploitation: Authorized attacker gains access to the system
  2. 2. Privilege Escalation: Attacker exploits double free vulnerability to elevate privileges
  3. 3. Post-Exploitation: Attacker gains unauthorized access to sensitive data and system resources

Am I Vulnerable?

  • Verify system logs for suspicious activity
  • Monitor system for unusual privilege escalations
  • Apply security patches and updates to affected systems

Operational Audit Arsenal

Target Type Windows Service
Target Asset Brokering File System
Standard Path C:\Windows\System32\drivers\
PowerShell
# 🛠️ Senior Engineer Universal Audit
# Target: Brokering File System (Windows Service)
$Targets = 'Brokering File System'
$SearchPaths = @("$env:windir\System32", "$env:ProgramFiles", "${env:ProgramFiles(x86)}")

Get-ChildItem -Path $SearchPaths -Include $Targets -Recurse -ErrorAction SilentlyContinue | 
Select-Object FullName, @{Name="Version";Expression={$_.VersionInfo.ProductVersion}}

Patch Impact Forecast

Reboot Required Likely

Potential disruption to system services and applications

Internal Work Notes

CVE-2026-32219: Double free vulnerability in Microsoft Brokering File System allows authorized attacker to elevate privileges locally. Apply security patches and updates to affected systems.

Technical Intelligence & Operational Utilities • Delivered Weekly

Intelligence Sources

Related Microsoft Threats

Data compiled from NVD, MSRC, and CISA KEV Catalog. Intelligence synthesized via AI. Scripts provided for diagnostic purposes under MIT License.